WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000058362) NEUTROKINE-ALPHA BINDING PROTEINS AND METHODS BASED THEREON
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/058362    International Application No.:    PCT/US2000/007966
Publication Date: 05.10.2000 International Filing Date: 24.03.2000
Chapter 2 Demand Filed:    25.10.2000    
IPC:
A61K 38/00 (2006.01), C07K 14/52 (2006.01), C07K 14/715 (2006.01)
Applicants: HUMAN GENOME SCIENCES, INC. [US/US]; 9410 Key West Avenue, Rockville, MD 20850 (US) (For All Designated States Except US).
RUBEN, Steven, M. [US/US]; (US) (For US Only).
ULLRICH, Stephen [US/US]; (US) (For US Only).
BAKER, Kevin [GB/US]; (US) (For US Only)
Inventors: RUBEN, Steven, M.; (US).
ULLRICH, Stephen; (US).
BAKER, Kevin; (US)
Agent: HOOVER, Kenley, K.; Human Genome Sciences, Inc., 9410 Key West Avenue, Rockville, MD 20850 (US)
Priority Data:
60/126,599 26.03.1999 US
60/188,208 10.03.2000 US
Title (EN) NEUTROKINE-ALPHA BINDING PROTEINS AND METHODS BASED THEREON
(FR) NOUVELLES PROTEINES CAPABLES DE LIAISON AVEC LA NEUTROKINE ALPHA ET PROCEDES BASES SUR LESDITES PROTEINES
Abstract: front page image
(EN)The present invention relates to Neutrokine-alpha binding polypeptides (NAR). In particular, isolated nucleic acid molecules are provided encoding human NAR protein. NAR polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of NAR activity.
(FR)L'invention concerne des polypeptides capables de liaison avec la Neutrokine alpha (NAR). Elle porte notamment sur des molécules d'acide nucléique isolées codant pour ladite protéine NAR humaine. Des polypeptides NAR sont également décrits ainsi que des vecteurs, des cellules hôtes et des méthodes de recombinaison pour leur production. Elle se rapporte encore à des méthodes de criblage pour l'identification d'agonistes et d'antagonistes de l'activité de NAR.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)